&w=3840&q=100)
Shefali Jariwala death: How anti-ageing treatment & excessive weight training can lead to cardiac arrest; expert explains
Shefali Jariwala's sudden demise on Friday night due to cardiac arrest turned out to be shocking news across the nation. Her longtime doctor told ABP News that she was undergoing anti-ageing treatment for the last five-six years, further revealing that she didn't have any serious heart condition either and always made sure to stay fit and healthy.
Reports also suggested that she was also doing excessive weight training along with anti-ageing treatment, which involved the use of Vitamin C and a drug called Glutathione.
STORY CONTINUES BELOW THIS AD
Dr Swarup Swaraj Pal, Sr. Consultant Cardiovascular and Thoracic surgeon, Gleneagles Hospitals from Parel, has shared valuable insights on how anti-ageing treatment & excessive weight training can lead to cardiac arrest .
Excessive weight lifting, Protein shakes, anti-ageing pills, and injections can cause cardiac arrest
According to various studies, excessive weightlifting puts too much strain on the heart, especially when done without proper rest or supervision. Some protein shakes contain added stimulants or steroids, which can raise blood pressure and heart rate. Anti-ageing pills and injections may contain hormones or chemicals that tend to disturb the heart rhythm. Hence, it is believed that these can increase the risk of heart problems or sudden cardiac arrest.
The major risks of heart attacks
Major risks of heart attacks are high blood pressure, high cholesterol, and diabetes. Smoking, obesity, and a lack of physical activity also raise one's chances of suffering from a heart attack. Moreover, stress and a family history of heart disease shouldn't be overlooked. Unhealthy eating and excessive alcohol can also impact the heart and lead to a heart attack.
The body gives signals that we need to pay attention to
Remember that the body gives certain warning signs before a heart problem, like chest pain or tightness, shortness of breath, and sudden fatigue. Also, pain may spread to the arms, neck, or jaw. Apart from this, there can be other symptoms such as dizziness, cold sweats, or fainting. Ignoring these can land you in trouble. Hence, it is necessary to immediately consult the doctor after these signs are observed. Timely intervention is key.
On Friday night, Shefali was rushed to Bellevue Multispeciality Hospital by her husband, Parag Tyagi, but she was declared dead on arrival.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
India.com
16 hours ago
- India.com
Shefali Jariwala's Sudden Death Raises Red Flags Over Anti-Ageing Treatments
The untimely death of Bollywood personality Shefali Jariwala, best known for her iconic role in Kaanta Laga, has sent shockwaves across the nation. At just 42, her sudden cardiac arrest on June 27, 2025, left fans and colleagues in disbelief. She was reportedly rushed to Bellevue Multispecialty Hospital in Andheri by her husband, actor Parag Tyagi, but was tragically declared dead on arrival. While police are still investigating the exact cause of her death, whispers around her long-term use of anti-ageing and skin-lightening treatments, including glutathione IV infusions, have come to the surface, raising serious concerns about the dark side of aesthetic wellness trends. What Experts Say: The Hidden Dangers of Anti-Ageing Therapies According to Dr BL Jangid, Dermatologist and Hair Transplant Surgeon at SkinQure Clinic, Delhi, the popularity of anti-ageing procedures, especially injectable treatments, has exploded in the last decade. 'From oral supplements to IV infusions, people are chasing youth without understanding the risks. And glutathione, unfortunately, is often marketed as a miracle,' warns Dr Jangid. What Is Glutathione and Why Is It Used? Glutathione is a natural antioxidant found in our body. It plays a key role in detoxification and cellular repair. In recent years, it has gained cult status in the skincare and wellness industry for: 1. Reducing pigmentation 2. Brightening the skin 3. Offering supposed 'anti-ageing' benefits It is available in oral capsules and intravenous infusions. And here's where the red flags begin. IV Glutathione: The Risky Shortcut to 'Youth' While oral glutathione supplements are generally safe under prescribed dosages, IV glutathione is far more controversial. The intravenous form introduces high doses directly into the bloodstream, often without proper regulatory guidelines. Dr Jangid reveals risks and possible side effects of IV Glutathione: 1. Allergic reactions and skin rashes 2. Inflammation and respiratory distress 3. Worsening of asthma symptoms 4. Damage to liver and kidney functions 5. Potential cardiac strain when administered in high, unregulated doses 'There are no globally accepted safety standards for IV glutathione doses,' says Dr Jangid. 'Unregulated clinics and salons offering such treatments are playing with people's lives.' What You Should Know Before Opting for Any Anti-Ageing Therapy 1. Always consult a qualified dermatologist or plastic surgeon 2. Avoid treatments at salons, spas, or unlicensed beauty clinics 3. If necessary, choose oral supplements under medical guidance 4. Demand full information about dosage, risks, and alternative options 'It's crucial to treat your skin like an organ, not a canvas. Anti-ageing should be medically monitored, not driven by trends,' Dr Jangid explains. Is Beauty Worth the Risk? Shefali's case may serve as a wake-up call. As aesthetics and beauty standards drive demand for quick fixes, consumers need to be better informed about the potential life-threatening complications of unregulated treatments. Dr Jangid stresses, "No anti-ageing result is worth endangering your life." Glutathione may promise a brighter, younger you, but when taken without medical supervision, especially via IV, it may lead to irreversible harm. Beauty, after all, is only skin deep. But your health? That's a life-or-death decision.
Economic Times
16 hours ago
- Economic Times
Young and fit dropping dead: A sector comes into focus
The recent death of Shefali Jariwala, best known for the 2002 chartbuster 'Kaanta Laga', due to cardiac arrest, has again brought to light the increasing trend of young, healthy and fit Indians suddenly dying of heart attack. In the past few years, several celebrities, such as Sidharth Shukla and Puneeth Rajkumar, have died due to cardiac issues. Heart attack incidents which used to affect mainly older adults now appear with increasing frequency among people under 50 years of age. The epidemic of cardiovascular diseases in India has created a lot of awareness about timely diagnosis among people which puts the focus on an emerging segment in India's healthcare sector -- diagnostics. India's diagnostics sector is undergoing a significant transformation, shifting from a fragmented business to a structured and tech-driven industry. Recently, Amazon announced its foray into the diagnostics space, marking a defining moment in this evolution. With an estimated market size of $25 billion and rapid growth, diagnostics is emerging as one of the most promising segments in Indian healthcare. But what triggered this boom? What forces are shaping its future? And is there a link to the rise in sudden heart attacks among India's young population? The COVID-19 pandemic was a catalyst that brought diagnostics to the forefront of healthcare. Once seen as a backend service, diagnostic testing has now become integral to proactive health management. More Indians are choosing routine screenings and preventive tests over symptomatic treatment. The shift in mindset, from illness-based to wellness-based healthcare, has been profound. This behavioral transformation laid the groundwork for diagnostics to flourish across urban and semi-urban the pandemic, diagnostic players were overloaded with work. Their bottom lines were getting better every single quarter. Between FY20 and FY22 – in just two years – literally all the companies saw a growth of more than 50% in absolute revenue numbers, as per a recent ET report. Once the pandemic ended, the workload returned to normal. The cash generated during Covid was utilized by different companies in different ways. Some used it to reduce their debt burden, others used it for expansion, using the cash for mergers that turned them from regional to national players. Post-pandemic, the demand for diagnostic services has surged, not only because of higher health awareness but also due to the lingering effects of the virus, which prompted many to seek tests related to heart health, respiratory function, and immune markers. India's recent diagnostics growth is also closely linked to the rising incidence of non-communicable diseases (NCDs). Conditions such as cardiovascular diseases (CVD), diabetes, hypertension and cancer are being detected at younger ages and are increasingly prevalent even in tier-2 and tier-3 cities. This has naturally escalated the demand for laboratory tests and imaging services. There has been a noted increase in sudden heart attacks among young and seemingly fit Indians, especially post-COVID. While there is no direct data attributing this to the boom in diagnostics, the phenomenon has contributed to an increase in cardiovascular screenings such as lipid profiles, ECGs and stress tests. As more individuals seek to understand their cardiac risk, diagnostics have become a proactive tool for early detection. The Indian diagnostics sector is transitioning rapidly from unorganised, standalone labs to structured, pan-India diagnostic chains. Organised players such as Dr Lal PathLabs, Metropolis, Thyrocare and SRL Diagnostics are increasing their footprints through franchise models and acquisitions. Organised diagnostic labs currently command around 15% market share but this is rising steadily, according to a recent report by PhillipCapital. The market is characterized by a high degree of fragmentation, with hospital-based labs holding a 37% share and unorganized standalone labs controlling the remaining 48%. Amazon India's recent launch of its diagnostics service in collaboration with Orange Health Labs is a significant milestone for the sector. The service, currently available in six major cities and 450+ PIN codes, offers over 800 tests with home sample collection in under 60 minutes and reports delivered within six entry not only validates the sector's growth potential but also intensifies competition. Following Amazon's announcement, shares of major diagnostic players like Dr Lal PathLabs and Metropolis fell by up to 3%, reflecting market concerns about pricing pressures and customer retention. Amazon brings scale, tech infrastructure and a convenience-first model, which could redefine customer expectations in diagnostics, especially in urban centers. One of the most promising aspects of the diagnostics sector is its expansion beyond metros. Non-metro cities are witnessing an annual growth rate of 20–25% in diagnostics demand, compared to 10% in metro cities. Rising health awareness, increasing affluence, and better insurance penetration are enabling residents in smaller towns to opt for preventive testing. Organised players are aggressively entering these markets, setting up franchise labs, mobile collection centers and even partnering with local clinics to provide high-quality testing services. The demand surge from rural and semi-urban areas is expected to play a pivotal role in the sector's growth trajectory over the next five years. Recently, Suraksha Diagnostics said it will invest Rs 200 crore to set up over 20 advanced imaging centres across eastern India. The plan, which will be executed in collaboration with United Imaging, is aimed at expanding access to advanced diagnostic services in tier 2 and tier 3 cities, enhancing both affordability and healthcare quality in smaller towns and semi-urban regions, it said. The Indian government's healthcare initiatives, particularly Ayushman Bharat, have improved access to diagnostics for a broader population. Additionally, state-level Public-Private Partnership models in radiology, such as the Punjab government's tie-up with private players for operating MRI and CT scan centers, are helping bridge infrastructure insurance is also becoming more inclusive of diagnostics, covering pre-emptive testing and annual health checks. As out-of-pocket expenses decline, more individuals are accessing regular testing services, further supporting sectoral diagnostics sector remains under-penetrated compared to global standards. When measured by the number of tests conducted per person each year, India lags far behind other developing nations such as Brazil and Saudi Arabia--even though India has the largest population in the world. This indicates that there is still a huge untapped demand for diagnostics services in the country, as per the PhillipCapital report. The diagnostic sector in India is expected to grow at a compound annual growth rate (CAGR) of around 14% through FY2028, according to the PhillipCapital report. Radiology services alone are projected to expand from $7.1 billion in FY2025 to $13.5 billion by FY2030. The expansion will be led by increased adoption of AI in medical imaging, growth in home-based testing and broader genomic and personalised medicine challenges remain. Pricing pressures from new entrants like Amazon, quality standardisation in smaller labs and the need for improved regulation and accreditation are ongoing issues. The government and industry will need to work in tandem to ensure that growth does not compromise accuracy or Indian diagnostics sector is no longer an auxiliary healthcare service. It is becoming a central pillar of the country's healthcare ecosystem. Driven by lifestyle changes, epidemiological shifts, digital innovation, and consumer demand, the sector is poised for sustained expansion. Amazon's entry marks a shift from traditional models to a more consumer-focused, tech-enabled and scalable diagnostic future. While the rise in sudden heart attacks among the young has brought cardiovascular diagnostics into focus, the sector's momentum is supported by a much broader wave of preventive health consciousness sweeping the nation. Diagnostics in India is not just booming; it is evolving and preparing to redefine how 1.4 billion people manage their health.
News18
17 hours ago
- News18
Shefali Jariwala's Death Raises Alarms Over Glutathione Injection Risks; Expert Answers
Last Updated: Shefali Jariwala's sudden death has sparked urgent conversations around the risks of unregulated glutathione injections and the dangers of low blood pressure after IV treatments The sudden and tragic death of actress-model Shefali Jariwala at the age of 42 has raised serious concerns about the safety of unregulated cosmetic treatments, particularly intravenous (IV) glutathione injections. While the official cause of death is yet to be confirmed, early reports suggest the possibility of cardiac arrest, potentially triggered by low blood pressure following a glutathione and Vitamin C injection administered on an empty stomach. In light of the incident, medical experts are sounding the alarm about the growing misuse of IV anti-ageing and skin-lightening treatments in non-clinical settings. Dr Sarita Sanke, Head of Cosmetology and Dermatology, Yashoda Cosmetic Boutique, Yashoda Superspeciality Hospital, Kaushambi, shares critical insights into the safe use of glutathione. 'The principle behind using Glutathione in skin lightening lies in its ability to decrease melanin production, thereby lightening the skin and reducing hyper pigmentation. Glutathione is available in multiple forms, oral supplements, topical applications, and intravenous (IV) injections and each has its own safety and efficacy profile," says Dr Sanke. She explains that oral glutathione especially in sublingual or effervescent dissolvable forms is considered among the safest options. It offers moderate skin-lightening effects with limited side effects and is generally well tolerated. Similarly, topical formulations may help improve skin tone and texture, although their effectiveness can vary. 'Intravenous glutathione, although known for its fast-acting results, carries serious safety risks, including the potential for anaphylactic reactions and liver toxicity. These risks are compounded by the absence of standardized dosing protocols and limited long-term safety data," she warns. As a result, IV glutathione should be approached with extreme caution and always under medical supervision. 1000–2000 mg per day for the first 3 months. 500 mg daily as a maintenance dose thereafter. Do not exceed 2000 mg per day, and avoid prolonged continuous use. IV administration (only under medical supervision): 1200–1800 mg per week for 4–6 weeks. Maintenance dose of 600–1200 mg per week. 'Always consult a healthcare provider before starting glutathione, especially if you are on other medications," she adds. 'The long-term systemic effects are not yet fully understood, so caution is advised with extended use. Watch for potential side effects such as low blood pressure or allergic reactions, particularly with IV use." Shefali Jariwala's death serves as a sobering reminder of the hidden risks involved in unmonitored cosmetic therapies. While beauty trends continue to drive demand for rapid results, experts like Dr Sanke stress the need for medical oversight, proper dosage, and a deep understanding of what our bodies can safely handle.
